MedTrace Logo

Thromboelastography-derived Functional Fibrinogen Levels

NCT01992757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2018-10-03

Study results available
· View outcomes & findings →

Summary

This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirements

Conditions

  • Focus of Study
  • Coagulation Status of Cardiac Surgery Patient
  • Reducing Excess Blood Transfusion

Sponsors & Collaborators

Principal Investigators

  • Prakash A Patel, MD · University of Pennsylvania Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992757 on ClinicalTrials.gov